Truist Financial Reaffirms Their Buy Rating on Exelixis (EXEL)
In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Exelixis (EXEL – Research Report). The ...
BioNTech initiated with a Buy at Citi
Citi analyst Geoff Meacham initiated coverage of BioNTech (BNTX) with a Buy rating and $145 price target Healthcare policy remains a key ...
Covid Vaccines Have Paved the Way for Cancer Vaccines
The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.
Health News Florida15h
NIH cuts off more research funding, including for vaccine hesitancy. mRNA may be next
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
Health News Florida15h
NIH cuts funding for vaccine-hesitancy research. mRNA research may be next
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
KSMU17h
NIH cuts funding for vaccine hesitancy research and may target mRNA research too
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how to increase uptake. mRNA vaccine research may be on the chopping block, too.